Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
 
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2017, Vol. 8 Issue (2) : 203-214     DOI: 10.14336/AD.2017.0305
Original Article |
Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke
Zhang Hongxia1,2, Sun Fen2, Wang Jixian2,3, Xie Luokun2, Yang Chenqi2, Pan Mengxiong1,2, Shao Bei1, Yang Guo-Yuan4, Yang Shao-Hua2, ZhuGe Qichuan1,*, Jin Kunlin1,2,*
1Zhejiang Provincial Key Laboratory of Aging and Neurological Disorder Research, First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China
2Institute for Healthy Aging, University of North Texas Health Science Center at Fort Worth, TX 76107, USA
3Department of Rehabilitation, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
4Med-x Research Institute, Shanghai Jiao Tong University, Shanghai, China
Download: PDF(1114 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    
Abstract  

Stroke survivors are typically left with structural brain damage and associated functional impairment in the chronic phase of injury, for which few therapeutic options exist. We reported previously that transplantation of human embryonic stem cell (hESC)-derived neural stem cells together with Matrigel scaffolding into the brains of rats after focal ischemia reduced infarct volume and improved neurobehavioral performance. Matrigel is a gelatinous protein mixture extracted from mouse sarcoma cells, thus would not be approved for use as a scaffold clinically. In this study, we generated a gel-like scaffold from plasma that was controlled by changing the concentration of CaCl2. In vitro study confirmed that 10-20 mM CaCl2 and 10-40% plasma did not affect the viability and proliferation of human and rat bone marrow mesenchymal stem/stromal cells (BMSCs) and neural stem cells (NSCs). We transplanted plasma scaffold in combination of BMSCs into the cystic cavity after focal cerebral ischemia, and found that the atrophy volume was dramatically reduced and motor function was significantly improved in the group transplanted with scaffold/BMSCs compared with the groups treated with vehicle, scaffold or BMSCs only. Our data suggest that plasma-derived scaffold in combination of BMSCs is feasible for tissue engineering approach for the stroke treatment.

Keywords senescence      aging      aging-related diseases      frailty      diagnosis      regulation     
Corresponding Authors: ZhuGe Qichuan,Jin Kunlin   
About author:

These authors contributed equally to this work

Issue Date: 01 April 2017
Service
E-mail this article
E-mail Alert
RSS
Articles by authors
Zhang Hongxia
Sun Fen
Wang Jixian
Xie Luokun
Yang Chenqi
Pan Mengxiong
Shao Bei
Yang Guo-Yuan
Yang Shao-Hua
ZhuGe Qichuan
Jin Kunlin
Cite this article:   
Zhang Hongxia,Sun Fen,Wang Jixian, et al. Combining Injectable Plasma Scaffold with Mesenchymal Stem/Stromal Cells for Repairing Infarct Cavity after Ischemic Stroke[J]. Aging and disease, 2017, 8(2): 203-214.
URL:  
http://www.aginganddisease.org/EN/10.14336/AD.2017.0305     OR     http://www.aginganddisease.org/EN/Y2017/V8/I2/203
Figure 1.  The effect of CaCl2, fibrinogen and thrombin on the formation of plasma gel in vitro. A) The time course of development of gelatinous clot of plasma in the presence of different concentrations of CaCl2. B) The effect of different concentrations of fibrinogen on the formation of gelatinous clot of plasma. C) The effect of different concentrations of thrombin with 20 mM CaCl2 on the formation of gelatinous clot of plasma. D) The comparison of different combinations of coagulation factors on formation of gelatinous clot of plasma. The experiments were repeated three times.
Figure 2.  The effect of different concentrations of CaCl2 and plasma on cell survival and death in vitro. A) The human BMSCs (hBMSCs) were treated with different concentrations of CaCl2 for 1, 2 and 3 days and CCK-8 proliferation assay was performed to determine the survival rate of hBMSCs. B) Human embryonic stem cells-derived NSCs were incubated with CaCl2 at different concentration as indicated and the proliferation rate of NSCs was determined by CCK-8 proliferation assay. C) Quantitation of calcein-AM fluorescent staining of rat BMSCs (rBMSCs) treated with different concentrations of CaCl2 for 1, 2 and 3 days. D) The HT-22 cells were treated with different concentrations of rat plasma and 10% FBS for 24 hrs and the survival rate of HT-22 cells was determined by MTT assay. E) The representative images of rBMSCs cultured in gelatinous plasma clot (30% rat plasma and 10uM CaCl2). Left panel: bright view of rBMSCs; middle panel: 2D view of GFP-positive rBMSCs; right panel: 3D view of GFP-positive rBMSCs. The experiments were repeated three times.
Figure 3.  BMSCs/plasma-derived scaffold transplantation reduced damaged volume of young adult rats after MCAO. A) Representative images of lesion areas in H&E-stained stained coronal brain sections from scaffold and BMSCs/scaffold-treated rats at 6 weeks after dMCAO. B) Quantitative analysis of damaged volume in vehicle (control), scaffold, BMSCs and BMSCs/scaffold-treated young rats 4 weeks after transplantation.
Figure 4.  BMSCs/plasma-derived scaffold transplantation improves long-term recovery after experimental stroke in young rats. BMSCs, scaffold, vehicle (control) or BMSCs/scaffold was implanted into brain cavity 3 weeks after MCAO and neurological behavioral tests including Bederson's test (A), Cylinder Test (B), EBST (C), and limb placing test (D), were performed at 1-4 weeks after transplantation. Values presented as mean ± SEM. *P < 0.05, compared with vehicle-treated group.
Figure 5.  BMSCs/plasma-derived scaffold transplantation improves long-term recovery after experimental stroke in young rats. BMSCs, scaffold, vehicle (control) or BMSCs/scaffold was implanted into brain cavity 3 weeks after MCAO and staggered ladder test was performed at 1-4 weeks after transplantation. Values presented as mean ± SEM. *P < 0.05, compared with vehicle-treated group
[1] Brott T, Bogousslavsky J (2000). Treatment of acute ischemic stroke. N Engl J Med, 343:710-722.
[2] Jin K, Sun Y, Xie L, Mao XO, Childs J, Peel A, et al. (2005). Comparison of ischemia-directed migration of neural precursor cells after intrastriatal, intraventricular, or intravenous transplantation in the rat. Neurobiol Dis, 18:366-374.
[3] Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al. (2004). Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. PNAS, 101:11839-11844.
[4] Kondziolka D, Wechsler L, Goldstein S, Meltzer C, Thulborn KR, Gebel J, et al. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology, 55:565-569.
[5] Colton CK (1995). Implantable biohybrid artificial organs. Cell Transplant, 4:415-436.
[6] Langer R, Vacanti JP (1993). Tissue engineering. Science, 260:920-926.
[7] Griffith LG (2002). Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann N Y Acad Sci, 961:83-95.
[8] Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S, So KF, et al. (2006). Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci U S A, 103:5054-5059.
[9] Hou S, Xu Q, Tian W, Cui F, Cai Q, Ma J, et al. (2005). The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J Neurosci Methods, 148:60-70.
[10] Deguchi K, Tsuru K, Hayashi T, Takaishi M, Nagahara M, Nagotani S, et al. (2006). Implantation of a new porous gelatin-siloxane hybrid into a brain lesion as a potential scaffold for tissue regeneration. J Cereb Blood Flow Metab, 26:1263-1273.
[11] Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, et al. (2002). Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. PNAS, 99:3024-3029.
[12] Tate MC, Shear DA, Hoffman SW, Stein DG, Archer DR, LaPlaca MC (2002). Fibronectin promotes survival and migration of primary neural stem cells transplanted into the traumatically injured mouse brain. Cell Transplant, 11:283-295.
[13] Park KI, Teng YD, Snyder EY (2002). The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol, 20:1111-1117.
[14] Jin K, Mao X, Xie L, Galvan V, Lai B, Wang Y, et al. (2009). Transplantation of human neural precursor cells in Matrigel scaffolding improves outcome from focal cerebral ischemia after delayed postischemic treatment in rats. J Cereb Blood Flow Metab.
[15] Shachar M, Cohen S (2003). Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors. Heart Fail Rev, 8:271-276.
[16] Ahmed TA, Dare EV, Hincke M (2008). Fibrin: a versatile scaffold for tissue engineering applications. Tissue engineering. Part B, Reviews, 14:199-215.
[17] Trombi L, Mattii L, Pacini S, D'Alessandro D, Battolla B, Orciuolo E, et al. (2008). Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 26:176-183.
[18] Harms PG, Ojeda SR (1974). A rapid and simple procedure for chronic cannulation of the rat jugular vein. Journal of applied physiology, 36:391-392.
[19] Grageda E (2004). Platelet-rich plasma and bone graft materials: a review and a standardized research protocol. Implant dentistry, 13:301-309.
[20] Wolfe M, Pochampally R, Swaney W, Reger RL (2008). Isolation and culture of bone marrow-derived human multipotent stromal cells (hMSCs). Methods Mol Biol, 449:3-25.
[21] Jin K, Mao XO, Batteur S, Sun Y, Greenberg DA (2003). Induction of neuronal markers in bone marrow cells: differential effects of growth factors and patterns of intracellular expression. Exp Neurol, 184:78-89.
[22] Jin K, Mao X, Xie L, Greenberg RB, Peng B, Moore A, et al. (2010). Delayed transplantation of human neural precursor cells improves outcome from focal cerebral ischemia in aged rats. Aging Cell, 9:1076-1083.
[23] Shin S, Mitalipova M, Noggle S, Tibbitts D, Venable A, Rao R, et al. (2006). Long-term proliferation of human embryonic stem cell-derived neuroepithelial cells using defined adherent culture conditions. Stem Cells, 24:125-138.
[24] Won SJ, Xie L, Kim SH, Tang H, Wang Y, Mao X, et al. (2006). Influence of age on the response to fibroblast growth factor-2 treatment in a rat model of stroke. Brain Res, 1123:237-244.
[25] Won SJ, Kim SH, Xie L, Wang Y, Mao XO, Jin K, et al. (2006). Reelin-deficient mice show impaired neurogenesis and increased stroke size. Exp Neurol, 198:250-259.
[26] Popa-Wagner A, Schroder E, Walker LC, Kessler C, Futrell N (1998). ß-Amyloid Precursor Protein and ß-Amyloid Peptide Immunoreactivity in the Rat Brain After Middle Cerebral Artery Occlusion : Effect of Age • Editorial Comment: Effect of Age. Stroke, 29:2196-2202.
[27] Hachinski VC, Wilson JX, Smith KE, Cechetto DF (1992). Effect of age on autonomic and cardiac responses in a rat stroke model. Arch Neurol, 49:690-696.
[28] Davis M, Mendelow AD, Perry RH, Chambers IR, James OFW (1995). Experimental Stroke and Neuroprotection in the Aging Rat Brain. Stroke, 26:1072-1078.
[29] Andersen MB, Zimmer J, Sams-Dodd F (1999). Specific behavioral effects related to age and cerebral ischemia in rats. Pharmacol Biochem Behav, 62:673-682.
[30] Parmentier-Batteur S, Bohme GA, Lerouet D, Zhou-Ding L, Beray V, Margaill I, et al. (2001). Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury. J Cereb Blood Flow Metab, 21:15-21.
[31] Parmentier S, Bohme GA, Lerouet D, Damour D, Stutzmann JM, Margaill I, et al. (1999). Selective inhibition of inducible nitric oxide synthase prevents ischaemic brain injury. Br J Pharmacol, 127:546-552.
[32] Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR (1990). A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab, 10:290-293.
[33] Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke, 17:472-476.
[34] De Ryck M, Van Reempts J, Borgers M, Wauquier A, Janssen P (1989). Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke, 20:1383-1390.
[35] Puurunen K, Jolkkonen J, Sirvio J, Haapalinna A, Sivenius J (2001). Selegiline combined with enriched-environment housing attenuates spatial learning deficits following focal cerebral ischemia in rats. Exp Neurol, 167:348-355.
[36] Schallert T, Hernandez TD, Barth TM (1986). Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res, 379:104-111.
[37] Cornelissen CG, Dietrich M, Kruger S, Spillner J, Schmitz-Rode T, Jockenhoevel S (2011). Fibrin Gel as Alternative Scaffold for Respiratory Tissue Engineering. Annals of biomedical engineering.
[38] Hunter AJ, Mackay KB, Rogers DC (1998). To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends Pharmacol Sci, 19:59-66.
[39] Metz GA, Whishaw IQ (2002). Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. Journal of neuroscience methods, 115:169-179.
[40] Ladenson JH, Tsai LM, Michael JM, Kessler G, Joist JH (1974). Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen? Am J Clin Pathol, 62:545-552.
[41] Gessmann J, Seybold D, Peter E, Schildhauer TA, Koller M (2013). Plasma clots gelled by different amounts of calcium for stem cell delivery. Langenbecks Arch Surg, 398:161-167.
[42] Matras H, Braun F, Lassmann H, Ammerer HP, Mamoli B (1973). Plasma clot welding of nerves (experimental report). Journal of maxillofacial surgery, 1:236-247.
[43] Barker CF, Billingham RE (1977). Immunologically privileged sites. Adv Immunol, 25:1-54.
[44] Tang Y, Yasuhara T, Hara K, Matsukawa N, Maki M, Yu G, et al. (2007). Transplantation of bone marrow-derived stem cells: a promising therapy for stroke. Cell Transplant, 16:159-169.
[45] Hunter AJ, Hatcher J, Virley D, Nelson P, Irving E, Hadingham SJ, et al. (2000). Functional assessments in mice and rats after focal stroke. Neuropharmacology, 39:806-816.
[46] Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, et al. (2011). Transplanted Stem Cell-Secreted VEGF Effects Post-Stroke Recovery, Inflammation, and Vascular Repair. Stem Cells.
[1] Tingting Sui,Di Liu,Tingjun Liu,Jichao Deng,Mao Chen,Yuanyuan Xu,Yuning Song,Hongsheng Ouyang,Liangxue Lai,Zhanjun Li. LMNA-mutated Rabbits: A Model of Premature Aging Syndrome with Muscular Dystrophy and Dilated Cardiomyopathy[J]. Aging and disease, 2019, 10(1): 102-115.
[2] Geraldo Rubens Ramos Freitas,Maria da Luz Fernandes,Fabiana Agena,Omar Jaluul,Sérgio Colenci Silva,Francine Brambate Carvalhinho Lemos,Verônica Coelho,David-Neto Elias,Nelson Zocoler Galante. Aging and End Stage Renal Disease Cause A Decrease in Absolute Circulating Lymphocyte Counts with A Shift to A Memory Profile and Diverge in Treg Population[J]. Aging and disease, 2019, 10(1): 49-61.
[3] Dong Liu,Liqun Xu,Xiaoyan Zhang,Changhong Shi,Shubin Qiao,Zhiqiang Ma,Jiansong Yuan. Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury[J]. Aging and disease, 2019, 10(1): 116-133.
[4] Wanying Duan, Yuehua Pu, Haiyan Liu, Jing Jing, Yuesong Pan, Xinying Zou, Yilong Wang, Xingquan Zhao, Chunxue Wang, Yongjun Wang, Ka Sing Lawrence Wong, Ling Wei, Liping Liu, . Association between Leukoaraiosis and Symptomatic Intracranial Large Artery Stenoses and Occlusions: the Chinese Intracranial Atherosclerosis (CICAS) Study[J]. Aging and disease, 2018, 9(6): 1074-1083.
[5] Calvin Pak-Wing Cheng, Sheung-Tak Cheng, Cindy Woon-Chi Tam, Wai-Chi Chan, Winnie Chiu-Wing Chu, Linda Chiu-Wa Lam. Relationship between Cortical Thickness and Neuropsychological Performance in Normal Older Adults and Those with Mild Cognitive Impairment[J]. Aging and disease, 2018, 9(6): 1020-1030.
[6] Yu-Wen Huang, Ming-Fu Chiang, Che-Sheng Ho, Pi-Lien Hung, Mei-Hsin Hsu, Tsung-Han Lee, Lichieh Julie Chu, Hsuan Liu, Petrus Tang, Wailap Victor Ng, Dar-Shong Lin. A Transcriptome Study of Progeroid Neurocutaneous Syndrome Reveals POSTN As a New Element in Proline Metabolic Disorder[J]. Aging and disease, 2018, 9(6): 1043-1057.
[7] Manuel Scimeca, Federica Centofanti, Monica Celi, Elena Gasbarra, Giuseppe Novelli, Annalisa Botta, Umberto Tarantino. Vitamin D Receptor in Muscle Atrophy of Elderly Patients: A Key Element of Osteoporosis-Sarcopenia Connection[J]. Aging and disease, 2018, 9(6): 952-964.
[8] Charlene Greenwood, John Clement, Anthony Dicken, Paul Evans, Iain Lyburn, Richard M. Martin, Nick Stone, Peter Zioupos, Keith Rogers. Age-Related Changes in Femoral Head Trabecular Microarchitecture[J]. Aging and disease, 2018, 9(6): 976-987.
[9] Junfen Fan, Xingyan An, Yanlei Yang, Haoying Xu, Linyuan Fan, Luchan Deng, Tao Li, Xisheng Weng, Jianmin Zhang, Robert Chunhua Zhao. MiR-1292 Targets FZD4 to Regulate Senescence and Osteogenic Differentiation of Stem Cells in TE/SJ/Mesenchymal Tissue System via the Wnt/β-catenin Pathway[J]. Aging and disease, 2018, 9(6): 1103-1121.
[10] Ashok K. Shetty, Maheedhar Kodali, Raghavendra Upadhya, Leelavathi N. Madhu. Emerging Anti-Aging Strategies - Scientific Basis and Efficacy[J]. Aging and disease, 2018, 9(6): 1165-1184.
[11] Ze Teng, Aibo Wang, Peng Wang, Rui Wang, Wei Wang, Hongbin Han. The Effect of Aquaporin-4 Knockout on Interstitial Fluid Flow and the Structure of the Extracellular Space in the Deep Brain[J]. Aging and disease, 2018, 9(5): 808-816.
[12] Stefano Rizza, Marina Cardellini, Alessio Farcomeni, Pasquale Morabito, Daniele Romanello, Giovanni Di Cola, Maria Paola Canale, Massimo Federici. Low Molecular Weight Adiponectin Increases the Mortality Risk in Very Old Patients[J]. Aging and disease, 2018, 9(5): 946-951.
[13] Patricia Sosa, Elena Alcalde-Estevez, Patricia Plaza, Nuria Troyano, Cristina Alonso, Laura Martinez-Arias, Andresa Evelem de Melo Aroeira, Diego Rodriguez-Puyol, Gemma Olmos, Susana Lopez-Ongil, Maria P. Ruiz-Torres. Hyperphosphatemia Promotes Senescence of Myoblasts by Impairing Autophagy Through Ilk Overexpression, A Possible Mechanism Involved in Sarcopenia[J]. Aging and disease, 2018, 9(5): 769-784.
[14] Stefanie Hardt, Lucie Valek, Jinyang Zeng-Brouwers, Annett Wilken-Schmitz, Liliana Schaefer, Irmgard Tegeder. Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus[J]. Aging and disease, 2018, 9(5): 817-830.
[15] Yong-Fei Zhao, Qiong Zhang, Jian-Feng Zhang, Zhi-Yin Lou, Hen-Bing Zu, Zi-Gao Wang, Wei-Cheng Zeng, Kai Yao, Bao-Guo Xiao. The Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease[J]. Aging and disease, 2018, 9(5): 785-797.
Viewed
Full text


Abstract

Cited

  Shared   
Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail: editorial@aginganddisease.org
Powered by Beijing Magtech Co. Ltd